Compare CVR & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVR | QNRX |
|---|---|---|
| Founded | 1920 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 10.1M |
| IPO Year | N/A | N/A |
| Metric | CVR | QNRX |
|---|---|---|
| Price | $13.23 | $9.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.4K | ★ 33.4K |
| Earning Date | 03-27-2026 | 03-12-2026 |
| Dividend Yield | ★ 0.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $26,008,045.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.15 | $5.01 |
| 52 Week High | $16.64 | $41.80 |
| Indicator | CVR | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.53 | 34.00 |
| Support Level | $12.20 | $9.59 |
| Resistance Level | $13.90 | $11.88 |
| Average True Range (ATR) | 0.53 | 0.84 |
| MACD | -0.25 | -0.24 |
| Stochastic Oscillator | 40.35 | 3.58 |
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.